Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
37.22
-0.22 (-0.59%)
Apr 24, 2025, 9:46 AM EDT - Market open

Revolution Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
6,9208,0834,7202,1151,8552,628
Upgrade
Market Cap Growth
71.26%71.26%123.15%14.03%-29.43%-
Upgrade
Enterprise Value
4,8076,6203,9691,5251,2782,195
Upgrade
Last Close Price
37.4443.7428.6823.8225.1739.59
Upgrade
PS Ratio
--407.5859.7863.1161.14
Upgrade
PB Ratio
3.073.572.583.093.085.54
Upgrade
P/TBV Ratio
3.173.682.693.463.516.58
Upgrade
EV/Sales Ratio
--342.7843.1143.4851.07
Upgrade
Debt / Equity Ratio
0.060.060.050.090.110.07
Upgrade
Asset Turnover
--0.010.050.050.11
Upgrade
Quick Ratio
13.9713.9712.8910.489.669.48
Upgrade
Current Ratio
14.2014.2013.0610.659.779.63
Upgrade
Return on Equity (ROE)
-29.33%-29.33%-34.75%-38.63%-34.73%-34.49%
Upgrade
Return on Assets (ROA)
-18.66%-18.66%-20.08%-20.83%-18.00%-17.56%
Upgrade
Return on Capital (ROIC)
-19.97%-19.97%-21.67%-22.76%-19.98%-20.96%
Upgrade
Earnings Yield
-8.62%-7.42%-9.25%-11.76%-10.09%-4.12%
Upgrade
FCF Yield
-8.16%-7.02%-7.59%-11.12%-8.29%-3.92%
Upgrade
Buyback Yield / Dilution
-48.24%-48.24%-40.34%-10.74%-32.68%-1879.16%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q